首页  | 新闻播报

每日新闻播报(October 25)

chinadaily.com.cn 2019-10-25 14:17

A logo sign of Biogen on April 29, 2019. [Photo/IC]

>First Alzheimer's drug
An American drug company, Biogen, surprised the medical world by announcing it has developed the first effective medicine that could slow down Alzheimer's disease, and it is now ready to bring it to the market.
The announcement came not long after the company discontinued work on the drug in March this year due to years of trial failures.
The drug, called aducanumab, neither prevents nor cures Alzheimer's, but helps slow down cognitive decline in some patients.
The drugmaker said it would soon seek regulatory approval in the US, which could take a year or two.
If successful, the company hopes to initially offer the drug to patients who had enrolled in clinical studies of the drug before.


Photo: Comfreak/Pixabay

>Selling your facial rights
According to a recent blog post by London-based outsourcing company Geomiq, a robotics company is currently looking for a "kind and friendly" face to put on a humanoid robot once it goes into production.
This will potentially entail using this person's face on thousands of robots around the world, so the company is willing to pay no less than £100,000 in licensing fees.
The robot in question is designed to be a "virtual friend" for elderly people, and is scheduled to go into production next year.
"We know that this is an extremely unique request, and signing over the licenses to your face is potentially an extremely big decision," Geomiq stated, adding that interested people can submit a photo of themselves via email.
The robotics company has reportedly been working on this particular humanoid robot for five years, and due to the secretive nature of the project, anonymity is of utmost importance.
However, candidates with the right kind of face chosen for the "next phase" will be given full details on the project.



>Sea bridge outperforms
The tourism and logistics sectors in Hong Kong, Macao and western Guangdong province have great market potential thanks in large part to the Hong Kong-Zhuhai-Macao Bridge, a year after the world's longest cross-sea thoroughfare opened to traffic, according to industry insiders.
The 55-kilometer bridge has served over 24 million passengers - an average 67,000 per day - since its opening on Oct 24 last year, according to the Guangdong government.
Over 70,000 vehicles from Hong Kong, Guangdong and Macao have registered to be able to use the bridge, and since its opening, over 1.5 million vehicles have crossed the bridge.


Yuan Longping, 89, known as the “father of hybrid rice”, shows visitors around a paddy in Hunan province Oct 22, 2019. [Photo/China News Service]

>Hybrid rice yields high
The third-generation hybrid rice developed by Yuan Longping, the "father of hybrid rice," and his team underwent its first public yield monitoring from Monday to Tuesday and achieved high output.
The final yield of the tested variety, G3-1S/P19, came to 1,046.3 kg per mu, based on two plots of land in Qingzhu village under the city of Hengyang in central China's Hunan province.
Experts agreed that the rice has a stout stem, fertilizer tolerance, lodging resistance, large spike and more grains.
Unlike the previous two generations that required a large amount of water and fertilizers as well as demanding growing conditions and technological support, the third-generation hybrid rice is easier to be cultivated by ordinary farmers.
Some previous high-yielding hybrid rice varieties in China took 160 to even 180 days from sowing to harvesting, while the figure was shortened to around 125 days for the new variety.

Find more audio news on the China Daily app.